These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 17891370)

  • 41. Prospective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma.
    Müller-Horvat C; Radny P; Eigentler TK; Schäfer J; Pfannenberg C; Horger M; Khorchidi S; Nägele T; Garbe C; Claussen CD; Schlemmer HP
    Eur J Cancer; 2006 Feb; 42(3):342-50. PubMed ID: 16364631
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Elective full-body screening examinations: a plea for MRI.
    Goyen M; Debatin JF
    World Hosp Health Serv; 2005; 41(2):32-4, 40, 42. PubMed ID: 16104457
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Teleradiology: economic research analysis of CT investigations in a small hospital].
    Plathow C; Walz M; Essig M; Engelmann U; Schulz-Ertner D; Delorme S; Kauczor HU
    Rofo; 2005 Jul; 177(7):1016-26. PubMed ID: 15973605
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone.
    Ghanem N; Uhl M; Brink I; Schäfer O; Kelly T; Moser E; Langer M
    Eur J Radiol; 2005 Jul; 55(1):41-55. PubMed ID: 15950100
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Whole-body MR imaging of bone marrow.
    Schmidt GP; Schoenberg SO; Reiser MF; Baur-Melnyk A
    Eur J Radiol; 2005 Jul; 55(1):33-40. PubMed ID: 15950099
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Whole-body MR angiography using a novel 32-receiving-channel MR system with surface coil technology: first clinical experience.
    Fenchel M; Requardt M; Tomaschko K; Kramer U; Stauder NI; Naegele T; Schlemmer HP; Claussen CD; Miller S
    J Magn Reson Imaging; 2005 May; 21(5):596-603. PubMed ID: 15834920
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostic imaging costs: are they driving up the costs of hospital care?
    Beinfeld MT; Gazelle GS
    Radiology; 2005 Jun; 235(3):934-9. PubMed ID: 15833988
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cost-effectiveness of whole-body CT screening.
    Beinfeld MT; Wittenberg E; Gazelle GS
    Radiology; 2005 Feb; 234(2):415-22. PubMed ID: 15670999
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fast whole-body assessment of metastatic disease using a novel magnetic resonance imaging system: initial experiences.
    Schlemmer HP; Schäfer J; Pfannenberg C; Radny P; Korchidi S; Müller-Horvat C; Nägele T; Tomaschko K; Fenchel M; Claussen CD
    Invest Radiol; 2005 Feb; 40(2):64-71. PubMed ID: 15654249
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PET and prostate cancer.
    Sanz G; Rioja J; Zudaire JJ; Berián JM; Richter JA
    World J Urol; 2004 Nov; 22(5):351-2. PubMed ID: 15503049
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Whole-body MRI in comparison to skeletal scintigraphy for detection of skeletal metastases in patients with solid tumors].
    Ghanem N; Kelly T; Altehoefer C; Winterer J; Schäfer O; Bley TA; Moser E; Langer M
    Radiologe; 2004 Sep; 44(9):864-73. PubMed ID: 15351930
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Oncologic screening with whole-body MRI: possibilities and limitations].
    Schäfer JF; Fischmann A; Lichy M; Vollmar J; Fenchel M; Claussen CD; Schlemmer HP
    Radiologe; 2004 Sep; 44(9):854-63. PubMed ID: 15349733
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Whole-body tumor staging: MRI or FDG-PET/CT?].
    Antoch G; Vogt FM; Bockisch A; Ruehm SG
    Radiologe; 2004 Sep; 44(9):882-8. PubMed ID: 15349729
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Two-dimensional parallel acquisition technique in 3D MR colonography.
    Steidle G; Schäfer J; Schlemmer HP; Claussen CD; Schick F
    Rofo; 2004 Aug; 176(8):1100-5. PubMed ID: 15346285
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High spatial resolution whole-body MR angiography featuring parallel imaging: initial experience.
    Quick HH; Vogt FM; Maderwald S; Herborn CU; Bosk S; Göhde S; Debatin JF; Ladd ME
    Rofo; 2004 Feb; 176(2):163-9. PubMed ID: 14872368
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of [(18)F] FDG-PET, CT/MRI and tumor marker kinetics in the evaluation of post chemotherapy residual masses in metastatic germ cell tumors--prospects for management.
    Pfannenberg AC; Oechsle K; Bokemeyer C; Kollmannsberger C; Dohmen BM; Bares R; Hartmann JT; Vonthein R; Claussen CD
    World J Urol; 2004 Jun; 22(2):132-9. PubMed ID: 14735310
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Tumor staging with PET/CT. Detection of a second tumor].
    Gutzeit A; Debatin JF; Antoch G
    Rofo; 2004 Jan; 176(1):122-4. PubMed ID: 14712416
    [No Abstract]   [Full Text] [Related]  

  • 58. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology.
    Antoch G; Vogt FM; Freudenberg LS; Nazaradeh F; Goehde SC; Barkhausen J; Dahmen G; Bockisch A; Debatin JF; Ruehm SG
    JAMA; 2003 Dec; 290(24):3199-206. PubMed ID: 14693872
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer.
    Harisinghani MG; Barentsz J; Hahn PF; Deserno WM; Tabatabaei S; van de Kaa CH; de la Rosette J; Weissleder R
    N Engl J Med; 2003 Jun; 348(25):2491-9. PubMed ID: 12815134
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preoperative breast cancer staging: MR imaging of the axilla with ultrasmall superparamagnetic iron oxide enhancement.
    Michel SC; Keller TM; Fröhlich JM; Fink D; Caduff R; Seifert B; Marincek B; Kubik-Huch RA
    Radiology; 2002 Nov; 225(2):527-36. PubMed ID: 12409591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.